𝔖 Bobbio Scriptorium

✦ LIBER ✦

177: Use of fetal magnetic resonance imaging (MRI) for the evaluation of fetal anomalies detected by standard obstetrical ultrasound (US)

✍ Scribed by Lesley Bevan; Francesca Facco; Svena Julien; Talbot Christopher

Book ID: 113432827
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 48 KB
Volume: 197
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2007.10.189

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relationship between fetal head station

Relationship between fetal head station established using an open magnetic resonance imaging scanner and the angle of progression determined by transperineal ultrasound

✍ C. Bamberg; S. Scheuermann; T. Slowinski; A. M. Dückelmann; M. Vogt; T. N. Nguye 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB

OP03.02: Prospective evaluation of the u

OP03.02: Prospective evaluation of the usefulness of one-step combined examination of fetal CNS by specialized 2D/3D neurosonogram and fetal magnetic resonance in the group of fetuses referred for ventriculomegaly

✍ V. Frisova; Z. Bejlkova; M. Kyncl; B. Prosova; R. Vlk; D. Smetanova; L. Haakova; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB